FDA approves generic Imitrex, Eloxatin from Sun

08/12/2009 | Reuters

Sun Pharmaceutical Industries obtained FDA clearance for its generic copies of GlaxoSmithKline's migraine drug Imitrex and Sanofi-Aventis' cancer drug Eloxatin. The Indian company said it will share a 180-day market protection for generic Eloxatin with three other drug firms.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX